Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 4.44 % |
3 Month Return | -12.32 % |
1 Year Return | -23.98 % |
Market Stats | |
Previous Close | ₹124.94 |
Open | ₹125.10 |
Volume | 4.83L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹542.86Cr |
P/E Ratio | -125.65 |
PEG Ratio | 8.51 |
Market Cap | ₹542.86 Cr |
P/B Ratio | 2.67 |
EPS | 0.07 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | -1.7 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹542.86 Cr | -4.8% | 0.60 | ₹29 Cr | ₹182 Cr | |
BUY | ₹4,215.47 Cr | 7.77% | 0.63 | ₹94 Cr | ₹1,081 Cr | |
NA | ₹521.96 Cr | 32.07% | 0.51 | NA | NA | |
BUY | ₹11,736.94 Cr | 316.22% | 0.50 | ₹314 Cr | ₹2,177 Cr | |
NA | ₹326.38 Cr | 145.42% | 0.66 | ₹5 Cr | ₹155 Cr |
Organisation | Valiant Laboratories Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Valiant Laboratories Ltd
Valiant Laboratories Limited has a return on equity (ROE) of 24%, which is higher than the industry average of 13%. The company also has a low debt to equity ratio of 0.58, suggesting it's worth watching. However, other factors such as future profit growth and investment requirements should be considered before investing.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 21.55% to 23.17% in Jun 2024 quarter
Profit Spike
Netprofit is up for the last 3 quarters, -3.5 Cr → -0.51 Cr (in ₹), with an average increase of 162.7% per quarter
Price Rise
In the last 7 days, VALIANTLAB stock has moved up by 12.5%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.94% of holdings in Jun 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 3.48% to 1.89% in Jun 2024 quarter
Revenue Fall
Revenue is down for the last 4 quarters, 62.51 Cr → 21.7 Cr (in ₹), with an average decrease of 29.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 74.94% | 0.00 | |
Foreign Institutions | 1.89% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 23.17% | 7.52 | |
Others | 0% |
Valiant Laboratories Ltd in the last 5 years
Lowest (-147.86x)
July 11, 2024
Today (-125.65x)
September 6, 2024
Industry (59.14x)
September 6, 2024
Highest (413.29x)
April 10, 2024
Valiant Laboratories Ltd’s net profit fell -111.94% since last year same period to ₹0.51Cr in the Q1 2024-2025. On a quarterly growth basis, Valiant Laboratories Ltd has generated 58.87% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Valiant Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Valiant Laboratories Ltd (VALIANTLAB) share price today is ₹129.42
Valiant Laboratories Ltd is listed on NSE
Valiant Laboratories Ltd is listed on BSE
PE Ratio of Valiant Laboratories Ltd is -125.65
PE ratio = Valiant Laboratories Ltd Market price per share / Valiant Laboratories Ltd Earnings per share
Today’s traded volume of Valiant Laboratories Ltd(VALIANTLAB) is 4.83L.
Today’s market capitalisation of Valiant Laboratories Ltd(VALIANTLAB) is ₹542.86Cr.
Valiant Laboratories Ltd(VALIANTLAB | Price |
---|---|
52 Week High | ₹214.95 |
52 Week Low | ₹100.2 |
Valiant Laboratories Ltd(VALIANTLAB) share price is ₹129.42. It is down -39.79% from its 52 Week High price of ₹214.95
Valiant Laboratories Ltd(VALIANTLAB) share price is ₹129.42. It is up 29.16% from its 52 Week Low price of ₹100.2
Valiant Laboratories Ltd(VALIANTLAB | Returns |
---|---|
1 Day Returns | 4.48% |
1 Month Returns | 4.44% |
3 Month Returns | -12.32% |
1 Year Returns | -23.98% |